Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-1998 | 08-1997 | 08-1996 | 08-1995 | 08-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 350 | 730 | 960 | 90 | 960 |
| Marketable Securities | 450 | 400 | 420 | 1,650 | 1,230 |
| Receivables | 30 | 60 | 160 | 80 | 90 |
| Inventories | 40 | 40 | 70 | 60 | 80 |
| Other current assets | 10 | 20 | 20 | 20 | 0 |
| TOTAL | $880 | $1,250 | $1,630 | $1,900 | $2,360 |
| Non-Current Assets | |||||
| PPE Net | 170 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 50 | 10 | 20 | 135 | 10 |
| TOTAL | $220 | $10 | $20 | $135 | $10 |
| Total Assets | $1,110 | $1,440 | $1,740 | $2,160 | $2,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 20 | 20 | 10 | 50 |
| Accrued Expenses | 20 | 30 | 30 | 30 | 40 |
| TOTAL | $120 | $150 | $60 | $50 | $100 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $120 | $150 | $60 | $50 | $100 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -4,280 | -3,980 | -3,590 | -3,170 | -2,860 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $990 | $1,290 | $1,680 | $2,100 | $2,430 |
| Total Liabilities And Equity | $1,110 | $1,440 | $1,740 | $2,150 | $2,530 |